CFF Grant to Advance Nitric Oxide Therapy for NTM Pulmonary Disease
Over $2 million in CFF funding will support research into high concentration inhaled nitric oxide for the treatment of Nontuberculous Mycobacteria Pulmonary Disease (NTM).
Over $2 million in CFF funding will support research into high concentration inhaled nitric oxide for the treatment of Nontuberculous Mycobacteria Pulmonary Disease (NTM).